share_log

美诺华(603538.SH):阿托伐他汀钙原料药获得欧洲CEP证书

ningbo menovo pharmaceutical(603538.SH):アトルバスタチンカルシウム医薬品有効成分がヨーロッパのCEP証明書を取得

Gelonghui Finance ·  2024/09/19 01:24

ningbo menovo pharmaceutical (603538.SH) announced on September 19th that the company has received the European CE certificate (European Pharmacopoeia Suitability Certificate) for atorvastatin calcium (active pharmaceutical ingredient) issued by the European Directorate for the Quality of Medicines (EDQM). Atorvastatin calcium is a statin lipid-regulating drug with its main action site in the liver. It can reduce cholesterol synthesis, increase the synthesis of low-density lipoprotein receptors, lower blood cholesterol and low-density lipoprotein cholesterol levels, moderately decrease serum triglyceride levels, and increase blood high-density lipoprotein cholesterol levels.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする